Format

Send to

Choose Destination
Blood Press. 2019 Aug;28(4):215-216. doi: 10.1080/08037051.2019.1625523. Epub 2019 Jun 11.

The PARAGON Heart Failure trial - ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction.

Author information

1
a Department of Cardiology , University of Oslo , Ullevaal Hospital , Oslo , Norway.
2
b Department of Hypertension and Diabetology , Medical University of Gdansk , Gdansk , Poland.
3
c Service of Nephrology and Hypertension , Centre Hospitalier Universitaire Vaudois , Lausanne , Switzerland.
4
d Vascular Biology and Hypertension Program, Department of Medicine , University of Alabama at Birmingham , Birmingham , AL , USA.

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center